Apex Healthcare Bhd (7090) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Apex Healthcare Bhd (7090) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM29.41 Million ≈ $7.38 Million USD) by net assets (RM779.26 Million ≈ $195.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 7090 market cap for the company's overall valuation and market capitalisation.
Apex Healthcare Bhd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Apex Healthcare Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Apex Healthcare Bhd stock price for real-time trading data and today's change.
Apex Healthcare Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apex Healthcare Bhd ranked by their cash flow conversion efficiency. Review 7090 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Guangdian Electric Group Co Ltd
SHG:601616
|
-0.002x |
|
Zhejiang Natural Outdoor Goods Inc.
SHG:605080
|
N/A |
|
Unifique Telecomunicações S.A.
SA:FIQE3
|
0.145x |
|
PTC India Limited
NSE:PTC
|
0.317x |
|
Jiangsu Baoli Asphalt
SHE:300135
|
-0.022x |
|
Diamond Hill Investment Group Inc
NASDAQ:DHIL
|
0.095x |
|
Brainsway Ltd
NASDAQ:BWAY
|
0.080x |
|
B+S GROUP SA INH EO-06
F:70B
|
N/A |
Annual Cash Flow Conversion Efficiency for Apex Healthcare Bhd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Apex Healthcare Bhd from 2012 to 2024. Also see total assets of Apex Healthcare Bhd for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | RM789.62 Million ≈ $198.25 Million |
RM69.00 Million ≈ $17.32 Million |
0.087x | +23.08% |
| 2023-12-31 | RM918.27 Million ≈ $230.55 Million |
RM65.19 Million ≈ $16.37 Million |
0.071x | -44.99% |
| 2022-12-31 | RM558.43 Million ≈ $140.20 Million |
RM72.07 Million ≈ $18.09 Million |
0.129x | +5.82% |
| 2021-12-31 | RM506.86 Million ≈ $127.26 Million |
RM61.82 Million ≈ $15.52 Million |
0.122x | -33.24% |
| 2020-12-31 | RM467.97 Million ≈ $117.49 Million |
RM85.49 Million ≈ $21.46 Million |
0.183x | +13.81% |
| 2019-12-31 | RM425.53 Million ≈ $106.84 Million |
RM68.30 Million ≈ $17.15 Million |
0.161x | +53.12% |
| 2018-12-31 | RM385.99 Million ≈ $96.91 Million |
RM40.46 Million ≈ $10.16 Million |
0.105x | -22.33% |
| 2017-12-31 | RM343.23 Million ≈ $86.17 Million |
RM46.32 Million ≈ $11.63 Million |
0.135x | +24.58% |
| 2016-12-31 | RM311.97 Million ≈ $78.33 Million |
RM33.80 Million ≈ $8.49 Million |
0.108x | +35.65% |
| 2015-12-31 | RM288.00 Million ≈ $72.31 Million |
RM23.00 Million ≈ $5.77 Million |
0.080x | -40.67% |
| 2014-12-31 | RM260.00 Million ≈ $65.28 Million |
RM35.00 Million ≈ $8.79 Million |
0.135x | +17.17% |
| 2013-12-31 | RM235.00 Million ≈ $59.00 Million |
RM27.00 Million ≈ $6.78 Million |
0.115x | -19.95% |
| 2012-12-31 | RM216.00 Million ≈ $54.23 Million |
RM31.00 Million ≈ $7.78 Million |
0.144x | -- |
About Apex Healthcare Bhd
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more